Arcus Biosciences, Inc (RCUS)

Trade RCUS now with
11/28/2022 8:47:30 AM Gilead, Arcus Announce Update On Joint TIGIT Program From Interim Analysis Of ARC-7 Study In Non-Small Cell Lung Cancer
8/8/2022 4:28:35 PM Arcus Biosciences Appoints Dimitry Nuyten As Chief Medical Officer
8/4/2022 1:13:56 PM Wedbush Is Lowering Arcus Biosciences, Inc (RCUS) FY22 Estimate To -4.08 From -3.93
8/4/2022 1:13:42 PM Wedbush Is Cutting Arcus Biosciences, Inc (RCUS) Q4 22 Estimate To -1.14 From -1.06
8/4/2022 1:13:26 PM Wedbush Is Lowering Arcus Biosciences, Inc (RCUS) Q3 22 Estimate To -1.06 From -0.99
8/4/2022 1:13:01 PM Wedbush Reiterates Arcus Biosciences, Inc (RCUS) At Outperform With $36 Down From $42 Price Target
5/11/2022 10:41:50 AM Arcus Biosciences Stock Tanks 27%
1/10/2022 8:13:39 AM Arcus Biosciences Provides Update On Clinical Programs, Incl 2022 Milestones
11/30/2021 1:05:01 AM Taiho Pharma Exercises Option For License To Arcus Biosciences' Anti-TIGIT Program In Japan &Certain Territories In Asia
6/24/2021 10:44:04 AM Arcus Biosciences Rises 15%
2/1/2021 8:06:07 AM Gilead Sciences To Raise Ownership Stake In Arcus To 19.5%, To Buy About 5.65 Mln Addl. Shares For $39/shr
1/15/2021 8:17:51 AM Arcus Biosciences Presents Promising Initial Data From Phase 1 Portion Of ARC-8 Study For AB680
1/6/2021 4:51:52 PM Arcus Biosciences Appoints Andrew Perlman And Michael Quigley To Its Board Of Directors
3/8/2019 6:58:57 AM Wedbush Is Raising Arcus Biosciences, Inc (RCUS) FY19 Estimate To -1.42 From -1.93